PeopleBio, Inc. (KOSDAQ:304840)
South Korea flag South Korea · Delayed Price · Currency is KRW
561.00
-9.00 (-1.58%)
At close: Jul 31, 2026

PeopleBio Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
301.8380.11,262691.1813,64338,810
Short-Term Investments
--4,1314,2539,020120.3
Trading Asset Securities
--1,000300--
Cash & Short-Term Investments
301.8380.16,3935,24422,66438,930
Cash Growth
-91.16%-98.75%21.91%-76.86%-41.78%315.70%
Accounts Receivable
906.611,2672,8343,1401,63852.75
Other Receivables
86.7264.3474.6753.962.5314.44
Receivables
1,3622,1313,6453,9941,700290.08
Inventory
1,1011,8162,6982,311540.33327.33
Prepaid Expenses
471.3448.17263.15213.28473.49159.14
Other Current Assets
229.38282.324,0763,0473,964438.43
Total Current Assets
3,4664,35717,07614,81029,34140,145
Property, Plant & Equipment
460.1235,6062,4543,5503,6722,289
Long-Term Investments
2,0643,4904,3725,7535,5845,020
Goodwill
--379.86379.86379.86379.86
Other Intangible Assets
2.82.972,2782,6012,9183,225
Long-Term Accounts Receivable
771.93675.66----
Other Long-Term Assets
103,499440.66514.1486.75421.4289.44
Total Assets
110,26344,57227,07527,58042,31651,348

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
99.273.960.07104.63261.269.4
Accrued Expenses
998.52115.99354.18519.67316.07110.17
Short-Term Debt
76,0417,3798,112895.6714,54312,412
Current Portion of Long-Term Debt
--435.323.544.064.68
Current Portion of Leases
297.95328.29413.58541.49420.18295.67
Other Current Liabilities
1,8766,1947,2391,46817,29216,434
Total Current Liabilities
79,31214,02116,5543,53332,83629,266
Long-Term Debt
---435.33438.8442.78
Long-Term Leases
152.2649.03291.19678.37945.83592.84
Pension & Post-Retirement Benefits
1,8271,7672,4673,1242,0541,964
Other Long-Term Liabilities
152.07116.31141.08146.17116.3666.87
Total Liabilities
81,44315,95419,4547,91736,39232,332

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
12,54710,61410,61410,5455,9065,622
Additional Paid-In Capital
79,74177,17977,17976,75449,43246,626
Retained Earnings
-99,042-95,044-79,228-68,450-51,549-37,228
Treasury Stock
-26.02-26.02-26.02-26.02--
Comprehensive Income & Other
35,60035,600-441.29-0-01,604
Total Common Equity
28,82028,3238,09818,8233,78916,625
Minority Interest
---772.52492.521,8452,101
Shareholders' Equity
28,82028,6187,62119,6645,92419,016
Total Liabilities & Equity
110,26344,57227,07527,58042,31651,348

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
76,4917,7569,2522,55416,35213,748
Net Cash (Debt)
-76,189-7,676-2,8592,6906,31225,182
Net Cash Growth
----57.39%-74.94%175.24%
Net Cash Per Share
-3372.81-352.75-131.50162.28431.461569.96
Filing Date Shares Outstanding
25.0421.1721.1721.0314.1113.43
Total Common Shares Outstanding
25.0421.1721.1721.0314.1113.43
Working Capital
-75,846-9,664521.811,276-3,49510,879
Book Value Per Share
1151.111337.86382.52894.97268.431237.50
Tangible Book Value
28,81728,3205,44015,842490.7113,020
Tangible Book Value Per Share
1151.001337.72256.97753.2534.77969.16
Machinery
1,8291,8292,7302,5702,2301,187
Construction In Progress
-35,600---204.75